|
Volumn 118, Issue 1, 2008, Pages 6-8
|
Intracoronary administration of abciximab in ST-elevation myocardial infarction.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
DRUG EFFECT;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
METHODOLOGY;
MICROCIRCULATION;
NOTE;
PATHOPHYSIOLOGY;
RISK FACTOR;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, INTRA-ARTERIAL;
INJECTIONS, INTRAVENOUS;
MICROCIRCULATION;
MYOCARDIAL INFARCTION;
RISK FACTORS;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
|
EID: 50949125212
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.108.780718 Document Type: Note |
Times cited : (14)
|
References (0)
|